High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

Arthritis and Rheumatism
Robert J VerburgJ van Laar

Abstract

To assess the feasibility, safety, and efficacy of high-dose chemotherapy and autologous hematopoietic stem cell transplantation (HSCT) in patients with severe, refractory rheumatoid arthritis (RA). Fourteen patients (3 male, 11 female, mean age 43 years, mean disease duration 10 years) with active, destructive, refractory RA entered the study. Autologous hematopoietic stem cells were collected by leukapheresis after mobilization with a single infusion of cyclophosphamide (CYC; 4 gm/m2) and subcutaneous injections of filgrastim (granulocyte colony-stimulating factor). Immunomagnetic selection of CD34+ cells from the leukapheresis products was performed to deplete potentially autoreactive lymphocytes. The conditioning regimen consisted of intravenous administration of high doses of CYC (cumulative dose 200 mg/kg), with subsequent reinfusion of the graft. Patients were monitored for disease activity, disability, adverse effects, and hematopoietic and immunologic reconstitution. All 14 patients completed the mobilization and leukapheresis procedures successfully, and 12 proceeded to receive conditioning and transplantation. Engraftment occurred in all of these patients, with rapid hematologic recovery. No major unexpected toxicity...Continue Reading

References

Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
Nov 14, 1997·British Journal of Haematology·J A SnowdenJ C Biggs
Jan 22, 2000·Arthritis and Rheumatism·G A SchellekensW J van Venrooij

❮ Previous
Next ❯

Citations

Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
Oct 15, 2003·Blood Reviews·Athanasios Fassas, Vassilios K Kimiskidis
Apr 19, 2002·International Immunopharmacology·Sarah J BinghamPaul Emery
Oct 3, 2009·Nature Reviews. Rheumatology·Jonathan H EsenstenJeffrey A Bluestone
Nov 20, 2002·British Journal of Haematology·Dominique FargeUNKNOWN Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·Nabil Saba, Thomas Flaig
Feb 24, 2004·Journal of Hematotherapy & Stem Cell Research·Athanasios Fassas, Aristide Kazis
Jul 14, 2004·Annals of the Rheumatic Diseases·D FargeUNKNOWN EBMT/EULAR Registry
Jun 1, 2011·Therapeutic Advances in Musculoskeletal Disease·Jacob M van Laar
Jan 12, 2005·Arthritis Research & Therapy·Frederique PonchelJohn D Isaacs
Oct 25, 2008·Arthritis Research & Therapy·Thomas Hügle, Jacob M van Laar
May 26, 2011·Expert Opinion on Biological Therapy·Margit ZeherPeter Szodoray
Oct 2, 2003·Expert Opinion on Biological Therapy·Alan Tyndall, Marco Matucci-Cerinic
Nov 10, 2005·Annals of Medicine·Esa Jantunen, Riitta Luosujärvi
Oct 30, 2008·Autoimmunity·Sofia Abrahamsson, Paolo A Muraro
Aug 26, 2004·British Journal of Haematology·Uday Popat, Robert Krance
Aug 11, 2004·Best Practice & Research. Clinical Haematology·John D Isaacs, Andreas Thiel
Sep 3, 2005·Autoimmunity Reviews·Paige de BuysDaniel E Furst
Feb 3, 2005·British Journal of Haematology·R E HoughN M Wulffraat
Nov 8, 2014·British Journal of Haematology·Paola CiprianiRoberto Giacomelli
Jan 29, 2002·Best Practice & Research. Clinical Rheumatology·J MooreP Brooks
Oct 10, 2013·Developmental Neurorehabilitation·Ben DeeryAndrew J Kornberg
Dec 27, 2005·Drug Discovery Today·Robert J Smith
Nov 5, 2005·Acta Haematologica·Alan Tyndall, Thomas Daikeler
Aug 11, 2004·Best Practice & Research. Clinical Haematology·S J Bingham, J J Moore
Jan 16, 2002·Lupus·A M Marmont
Mar 25, 2016·World Journal of Transplantation·Subramanian RamaswamyVinod Ravindran
Aug 31, 2004·Arthritis and Rheumatism·Richard K BurtWalter G Barr
Jun 8, 2002·Pharmacoepidemiology and Drug Safety
May 15, 2003·Arthritis and Rheumatism·Jacob M Van Laar, Steven Z Pavletic
Aug 22, 2003·Bone Marrow Transplantation·J J MooreR Burt
Mar 15, 2005·Bone Marrow Transplantation·A GratwohlUNKNOWN Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Mar 7, 2002·Current Opinion in Oncology·Robert A Brodsky
May 1, 2002·Current Opinion in Rheumatology·Daniel E Furst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.